rethinkPeptides Search
Menu
Research citation

Combined treatment of TKIs with Cilengitide overcomes afatinib-resistance in EGFR-mutated NSCLC cells.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Combined treatment of TKIs with Cilengitide overcomes afatinib-resistance in EGFR-mutated NSCLC cells.

Molecular biology reports, 53(1), 233

Citation

Kang, Hye Eun; Seo, Yujin; Kim, Yeonsoo; Kim, Jiyeon. (2025). Combined treatment of TKIs with Cilengitide overcomes afatinib-resistance in EGFR-mutated NSCLC cells.. Molecular biology reports, 53(1), 233. https://doi.org/10.1007/s11033-025-11405-2